Gut microbiome in endometriosis: a cohort study on 1000 individuals
Authors:
- Inmaculada Pérez-PrietoIPInmaculada Pérez-Prieto
- Estonian Biobank research teamETEstonian Biobank research team
- Metspalu MaitMMMetspalu Mait
Top Cited Papers
Open Access
- 18 July 2024
- journal article
- research article
- Published by Springer Nature in BMC Medicine
- Vol. 22 (1) , 1-12
Abstract
Background: Endometriosis, defined as the presence of endometrial-like tissue outside of the uterus, is one of the most prevalent gynecological disorders. Although different theories have been proposed, its pathogenesis is not clear. Novel studies indicate that the gut microbiome may be involved in the etiology of endometriosis; nevertheless, the connection between microbes, their dysbiosis, and the development of endometriosis is understudied. This case–control study analyzed the gut microbiome in women with and without endometriosis to identify microbial targets involved in the disease. Methods: A subsample of 1000 women from the Estonian Microbiome cohort, including 136 women with endometriosis and 864 control women, was analyzed. Microbial composition was determined by shotgun metagenomics and microbial functional pathways were annotated using the Kyoto Encyclopedia of Genes and Genomes (KEGG) database. Partitioning Around Medoids (PAM) algorithm was performed to cluster the microbial profile of the Estonian population. The alpha- and beta-diversity and differential abundance analyses were performed to assess the gut microbiome (species and KEGG orthologies (KO)) in both groups. Metagenomic reads were mapped to estrobolome-related enzymes’ sequences to study potential microbiome-estrogen metabolism axis alterations in endometriosis. Results: Diversity analyses did not detect significant differences between women with and without endometriosis (alpha-diversity: all p-values > 0.05; beta-diversity: PERMANOVA, both R2 < 0.0007, p-values > 0.05). No differential species or pathways were detected after multiple testing adjustment (all FDR p-values > 0.05). Sensitivity analysis excluding women at menopause (> 50 years) confirmed our results. Estrobolome-associated enzymes’ sequence reads were not significantly different between groups (all FDR p-values > 0.05). Conclusions: Our findings do not provide enough evidence to support the existence of a gut microbiome-dependent mechanism directly implicated in the pathogenesis of endometriosis. To the best of our knowledge, this is the largest metagenome study on endometriosis conducted to date.Keywords
This publication has 63 references indexed in Scilit:
- SOAPdenovo2: an empirically improved memory-efficient short-read de novo assemblerGigaScience, 2012
- A human gut microbial gene catalogue established by metagenomic sequencingNature, 2010
- SOAP2: an improved ultrafast tool for short read alignmentBioinformatics, 2009
- Oral eicosapentaenoic acid supplementation as possible therapy for endometriosisFertility and Sterility, 2008
- Fatty acid synthase and the lipogenic phenotype in cancer pathogenesisNature Reviews Cancer, 2007
- An obesity-associated gut microbiome with increased capacity for energy harvestNature, 2006
- Targeting Fatty Acid Synthase in Breast and Endometrial Cancer: An Alternative to Selective Estrogen Receptor Modulators?Endocrinology, 2006
- Automated genome annotation and pathway identification using the KEGG Orthology (KO) as a controlled vocabularyBioinformatics, 2005
- Expression of Fatty Acid Synthase Is Closely Linked to Proliferation and Stromal Decidualization in Cycling EndometriumInternational Journal of Gynecological Pathology, 1997
- Regulation of Fatty Acid Synthetase Ribonucleic Acid in the Human Endometrium during the Menstrual Cycle*The Journal of Clinical Endocrinology & Metabolism, 1990